返回 Agenda
Session Chair(s)
Su-Yueh Lin
Sr. Labeling Consultant, Regulatory Affairs
SYL Regulatory Consulting, Taiwan
Speaker(s)
Content and Format of the United States Prescribing Information (USPI) for Human Prescription Drug and Biological Products: Update on Labeling Guidances
Eric Brodsky, MD
FDA, United States
Associate Director, Labeling Development Team, Office of New Drugs, CDER